Angiotensin II in Liver Transplantation
Angiotensin II in Liver Transplantation
Active, not recruiting · NCT04901169 · Registry updated 2026-03-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Angiotensin II in Liver Transplantation | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Fibrosis, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Urogenital Diseases, Vasoplegia, acute kidney injury, cardiovascular disorder, hypotensive disorder, kidney disorder, kidney failure, urinary system disorder, vascular disorder | Active, not recruiting | Phase 2 / Phase 3 | 2026-03-20 | NCT04901169 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| La Jolla Pharmaceutical Company | 2 |
| University of California, San Francisco | 637 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of California, San Francisco | San Francisco | United States | 294 |